While hospital systems focus on more lucrative adult care operations, often sacrificing pediatric care in the process, the consequences of such decisions are often ignored, Brenna Miller, a health communications specialist at think tank the Lown Institute, wrote on its site Dec. 5.
More
The Lown Institute of Needham has long argued that hospitals perform way too many procedures it has identified as being low-value, meaning they offer little to no clinical benefit to patients and, in many cases, are more likely to harm them than help them.
More
It's the time of year where most of us are getting into the "giving spirit." But recent investigations show that some hospitals are instead putting up obstacles to financial assistance.
More
Pediatric units are closing across the country, leaving parents and their sick kids without easy access to healthcare. Why is this happening, and what are the long-term consequences?
More
The Lown Institute calls for greater transparency and accountability.
More
With $8 and 9 words, one internet troll is forcing insulin manufacturers to answer the question of why the drug is so unaffordable
More
Which hospitals are walking the talk on social responsibility? A new feature in Frontiers of Health Services Management showcases the Lown Index and winning hospitals.
More
A new report examining the finances of nonprofit hospitals in New York City finds that some hospitals fall significantly short on expected community investments.
More
Nominations for the annual Bernard Lown Award for Social Responsibility are now open!
More
What could be a fruitful conversation on racial equity is being co-opted by pharmaceutical companies to sell unproven drugs.
More
Fair share spending results Fair Share in the News Subscribe to the Lown Weekly Subscribe to our weekly newsletter to get free blogs, news, and updates on our projects. View/download slides
More
Skipping doses, intentionally undermedicating, not eating - these are all measures 1.3 million Americans are forced to take to keep their insulin costs down.
More
From approval to withdrawal, the story of Makena shows some of the major pitfalls of the FDA's drug approval process.
More
The Lown Institute's annual Shkreli Awards highlight the most egregious examples of profiteering and dysfunction in our healthcare system. From systemic failures to negligence to fraud, the Shkreli Awards are here to spotlight the worst. On January 10 at 1 pm ET, we will be counting down the top ten most glaring examples of our broken system, and you're invited!
More
These five events are the administrative equivalent of operating on the wrong limb...
More
The reasoning behind this decision has to do with a complex bioethical question - if there is the potential to treat a previously untreatable disease with a new pharmaceutical, but the consequences are unknown, do you prescribe the drug? Is the unknown enough to deny patients hope?
More